nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—chronic obstructive pulmonary disease	0.265	0.542	CbGaD
Ropinirole—HTR2A—chronic obstructive pulmonary disease	0.223	0.458	CbGaD
Ropinirole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0305	0.15	CbGbCtD
Ropinirole—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0296	0.145	CbGbCtD
Ropinirole—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0296	0.145	CbGbCtD
Ropinirole—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0264	0.129	CbGbCtD
Ropinirole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0248	0.122	CbGbCtD
Ropinirole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0168	0.0821	CbGbCtD
Ropinirole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.016	0.0783	CbGbCtD
Ropinirole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0143	0.0698	CbGbCtD
Ropinirole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00836	0.041	CbGbCtD
Ropinirole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0079	0.0387	CbGbCtD
Ropinirole—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00496	0.396	CbGeAlD
Ropinirole—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.0018	0.144	CbGeAlD
Ropinirole—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000536	0.0428	CbGeAlD
Ropinirole—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000459	0.0366	CbGeAlD
Ropinirole—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000456	0.0364	CbGeAlD
Ropinirole—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000387	0.0309	CbGeAlD
Ropinirole—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000367	0.0293	CbGeAlD
Ropinirole—ADRA2C—trachea—chronic obstructive pulmonary disease	0.00033	0.0263	CbGeAlD
Ropinirole—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000313	0.025	CbGeAlD
Ropinirole—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000303	0.0242	CbGeAlD
Ropinirole—HTR2B—lung—chronic obstructive pulmonary disease	0.000301	0.024	CbGeAlD
Ropinirole—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000293	0.0234	CbGeAlD
Ropinirole—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000266	0.0213	CbGeAlD
Ropinirole—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000263	0.021	CbGeAlD
Ropinirole—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000244	0.0194	CbGeAlD
Ropinirole—DRD2—lung—chronic obstructive pulmonary disease	0.000244	0.0194	CbGeAlD
Ropinirole—ADRA2C—lung—chronic obstructive pulmonary disease	0.000237	0.0189	CbGeAlD
Ropinirole—HTR2A—trachea—chronic obstructive pulmonary disease	0.000224	0.0178	CbGeAlD
Ropinirole—CYP1A2—lung—chronic obstructive pulmonary disease	0.000206	0.0164	CbGeAlD
Ropinirole—ADRA2A—lung—chronic obstructive pulmonary disease	0.000189	0.0151	CbGeAlD
Ropinirole—HTR2A—lung—chronic obstructive pulmonary disease	0.000161	0.0128	CbGeAlD
Ropinirole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000463	CcSEcCtD
Ropinirole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00046	CcSEcCtD
Ropinirole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000458	CcSEcCtD
Ropinirole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000458	CcSEcCtD
Ropinirole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000458	CcSEcCtD
Ropinirole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	9.98e-05	0.000456	CcSEcCtD
Ropinirole—Shock—Salbutamol—chronic obstructive pulmonary disease	9.97e-05	0.000456	CcSEcCtD
Ropinirole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	9.96e-05	0.000455	CcSEcCtD
Ropinirole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	9.94e-05	0.000454	CcSEcCtD
Ropinirole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.000454	CcSEcCtD
Ropinirole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	9.89e-05	0.000452	CcSEcCtD
Ropinirole—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.000452	CcSEcCtD
Ropinirole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	9.85e-05	0.00045	CcSEcCtD
Ropinirole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	9.8e-05	0.000448	CcSEcCtD
Ropinirole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	9.8e-05	0.000448	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	9.78e-05	0.000447	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	9.78e-05	0.000447	CcSEcCtD
Ropinirole—Insomnia—Formoterol—chronic obstructive pulmonary disease	9.71e-05	0.000444	CcSEcCtD
Ropinirole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	9.71e-05	0.000444	CcSEcCtD
Ropinirole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	9.66e-05	0.000441	CcSEcCtD
Ropinirole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	9.65e-05	0.000441	CcSEcCtD
Ropinirole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000439	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	9.58e-05	0.000438	CcSEcCtD
Ropinirole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	9.57e-05	0.000437	CcSEcCtD
Ropinirole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	9.57e-05	0.000437	CcSEcCtD
Ropinirole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	9.55e-05	0.000436	CcSEcCtD
Ropinirole—Somnolence—Formoterol—chronic obstructive pulmonary disease	9.55e-05	0.000436	CcSEcCtD
Ropinirole—Insomnia—Montelukast—chronic obstructive pulmonary disease	9.51e-05	0.000435	CcSEcCtD
Ropinirole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	9.47e-05	0.000433	CcSEcCtD
Ropinirole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	9.45e-05	0.000432	CcSEcCtD
Ropinirole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	9.45e-05	0.000432	CcSEcCtD
Ropinirole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	9.44e-05	0.000431	CcSEcCtD
Ropinirole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	9.41e-05	0.00043	CcSEcCtD
Ropinirole—Somnolence—Montelukast—chronic obstructive pulmonary disease	9.35e-05	0.000427	CcSEcCtD
Ropinirole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	9.33e-05	0.000426	CcSEcCtD
Ropinirole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.000425	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	9.27e-05	0.000423	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	9.27e-05	0.000423	CcSEcCtD
Ropinirole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	9.26e-05	0.000423	CcSEcCtD
Ropinirole—Fatigue—Formoterol—chronic obstructive pulmonary disease	9.26e-05	0.000423	CcSEcCtD
Ropinirole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	9.26e-05	0.000423	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	9.24e-05	0.000422	CcSEcCtD
Ropinirole—Constipation—Arformoterol—chronic obstructive pulmonary disease	9.18e-05	0.000419	CcSEcCtD
Ropinirole—Constipation—Formoterol—chronic obstructive pulmonary disease	9.18e-05	0.000419	CcSEcCtD
Ropinirole—Pain—Arformoterol—chronic obstructive pulmonary disease	9.18e-05	0.000419	CcSEcCtD
Ropinirole—Pain—Formoterol—chronic obstructive pulmonary disease	9.18e-05	0.000419	CcSEcCtD
Ropinirole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.17e-05	0.000419	CcSEcCtD
Ropinirole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000418	CcSEcCtD
Ropinirole—Amnesia—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000418	CcSEcCtD
Ropinirole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	9.1e-05	0.000416	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	9.08e-05	0.000415	CcSEcCtD
Ropinirole—Fatigue—Montelukast—chronic obstructive pulmonary disease	9.07e-05	0.000414	CcSEcCtD
Ropinirole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	9.04e-05	0.000413	CcSEcCtD
Ropinirole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	9.01e-05	0.000412	CcSEcCtD
Ropinirole—Pain—Montelukast—chronic obstructive pulmonary disease	8.99e-05	0.000411	CcSEcCtD
Ropinirole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	8.99e-05	0.000411	CcSEcCtD
Ropinirole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	8.97e-05	0.00041	CcSEcCtD
Ropinirole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	8.94e-05	0.000408	CcSEcCtD
Ropinirole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	8.94e-05	0.000408	CcSEcCtD
Ropinirole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	8.92e-05	0.000408	CcSEcCtD
Ropinirole—Purpura—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000407	CcSEcCtD
Ropinirole—Rash—Aminophylline—chronic obstructive pulmonary disease	8.9e-05	0.000406	CcSEcCtD
Ropinirole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	8.89e-05	0.000406	CcSEcCtD
Ropinirole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	8.86e-05	0.000405	CcSEcCtD
Ropinirole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	8.85e-05	0.000404	CcSEcCtD
Ropinirole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	8.85e-05	0.000404	CcSEcCtD
Ropinirole—Headache—Aminophylline—chronic obstructive pulmonary disease	8.84e-05	0.000404	CcSEcCtD
Ropinirole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	8.81e-05	0.000403	CcSEcCtD
Ropinirole—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000402	CcSEcCtD
Ropinirole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	8.8e-05	0.000402	CcSEcCtD
Ropinirole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	8.78e-05	0.000401	CcSEcCtD
Ropinirole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	8.78e-05	0.000401	CcSEcCtD
Ropinirole—Lethargy—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000401	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.75e-05	0.0004	CcSEcCtD
Ropinirole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	8.74e-05	0.000399	CcSEcCtD
Ropinirole—Pain—Salbutamol—chronic obstructive pulmonary disease	8.67e-05	0.000396	CcSEcCtD
Ropinirole—Constipation—Salbutamol—chronic obstructive pulmonary disease	8.67e-05	0.000396	CcSEcCtD
Ropinirole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	8.6e-05	0.000393	CcSEcCtD
Ropinirole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000393	CcSEcCtD
Ropinirole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000393	CcSEcCtD
Ropinirole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	8.53e-05	0.00039	CcSEcCtD
Ropinirole—Urticaria—Formoterol—chronic obstructive pulmonary disease	8.53e-05	0.00039	CcSEcCtD
Ropinirole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	8.49e-05	0.000388	CcSEcCtD
Ropinirole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	8.49e-05	0.000388	CcSEcCtD
Ropinirole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	8.49e-05	0.000388	CcSEcCtD
Ropinirole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	8.49e-05	0.000388	CcSEcCtD
Ropinirole—Affect lability—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000387	CcSEcCtD
Ropinirole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	8.46e-05	0.000386	CcSEcCtD
Ropinirole—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000384	CcSEcCtD
Ropinirole—Rash—Tiotropium—chronic obstructive pulmonary disease	8.39e-05	0.000383	CcSEcCtD
Ropinirole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	8.38e-05	0.000383	CcSEcCtD
Ropinirole—Nausea—Aminophylline—chronic obstructive pulmonary disease	8.38e-05	0.000383	CcSEcCtD
Ropinirole—Urticaria—Montelukast—chronic obstructive pulmonary disease	8.35e-05	0.000382	CcSEcCtD
Ropinirole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	8.35e-05	0.000382	CcSEcCtD
Ropinirole—Headache—Tiotropium—chronic obstructive pulmonary disease	8.33e-05	0.000381	CcSEcCtD
Ropinirole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	8.33e-05	0.000381	CcSEcCtD
Ropinirole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	8.31e-05	0.00038	CcSEcCtD
Ropinirole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	8.31e-05	0.00038	CcSEcCtD
Ropinirole—Face oedema—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000379	CcSEcCtD
Ropinirole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	8.29e-05	0.000379	CcSEcCtD
Ropinirole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	8.23e-05	0.000376	CcSEcCtD
Ropinirole—Irritability—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000375	CcSEcCtD
Ropinirole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	8.18e-05	0.000374	CcSEcCtD
Ropinirole—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000373	CcSEcCtD
Ropinirole—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000372	CcSEcCtD
Ropinirole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.05e-05	0.000368	CcSEcCtD
Ropinirole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.01e-05	0.000366	CcSEcCtD
Ropinirole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.01e-05	0.000366	CcSEcCtD
Ropinirole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	7.91e-05	0.000361	CcSEcCtD
Ropinirole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	7.91e-05	0.000361	CcSEcCtD
Ropinirole—Nausea—Tiotropium—chronic obstructive pulmonary disease	7.9e-05	0.000361	CcSEcCtD
Ropinirole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.00036	CcSEcCtD
Ropinirole—Dry skin—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.00036	CcSEcCtD
Ropinirole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000357	CcSEcCtD
Ropinirole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	7.75e-05	0.000354	CcSEcCtD
Ropinirole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	7.7e-05	0.000352	CcSEcCtD
Ropinirole—Asthenia—Formoterol—chronic obstructive pulmonary disease	7.7e-05	0.000352	CcSEcCtD
Ropinirole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	7.6e-05	0.000347	CcSEcCtD
Ropinirole—Pruritus—Formoterol—chronic obstructive pulmonary disease	7.6e-05	0.000347	CcSEcCtD
Ropinirole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000346	CcSEcCtD
Ropinirole—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000346	CcSEcCtD
Ropinirole—Asthenia—Montelukast—chronic obstructive pulmonary disease	7.55e-05	0.000345	CcSEcCtD
Ropinirole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.000342	CcSEcCtD
Ropinirole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	7.47e-05	0.000341	CcSEcCtD
Ropinirole—Pruritus—Montelukast—chronic obstructive pulmonary disease	7.44e-05	0.00034	CcSEcCtD
Ropinirole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	7.35e-05	0.000336	CcSEcCtD
Ropinirole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	7.35e-05	0.000336	CcSEcCtD
Ropinirole—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.000334	CcSEcCtD
Ropinirole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000333	CcSEcCtD
Ropinirole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.27e-05	0.000332	CcSEcCtD
Ropinirole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000331	CcSEcCtD
Ropinirole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.2e-05	0.000329	CcSEcCtD
Ropinirole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.17e-05	0.000328	CcSEcCtD
Ropinirole—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.1e-05	0.000324	CcSEcCtD
Ropinirole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.1e-05	0.000324	CcSEcCtD
Ropinirole—Dizziness—Montelukast—chronic obstructive pulmonary disease	6.95e-05	0.000318	CcSEcCtD
Ropinirole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	6.94e-05	0.000317	CcSEcCtD
Ropinirole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000313	CcSEcCtD
Ropinirole—Vomiting—Formoterol—chronic obstructive pulmonary disease	6.83e-05	0.000312	CcSEcCtD
Ropinirole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	6.83e-05	0.000312	CcSEcCtD
Ropinirole—Rash—Arformoterol—chronic obstructive pulmonary disease	6.77e-05	0.000309	CcSEcCtD
Ropinirole—Rash—Formoterol—chronic obstructive pulmonary disease	6.77e-05	0.000309	CcSEcCtD
Ropinirole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	6.76e-05	0.000309	CcSEcCtD
Ropinirole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	6.76e-05	0.000309	CcSEcCtD
Ropinirole—Weight increased—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000309	CcSEcCtD
Ropinirole—Headache—Arformoterol—chronic obstructive pulmonary disease	6.73e-05	0.000307	CcSEcCtD
Ropinirole—Headache—Formoterol—chronic obstructive pulmonary disease	6.73e-05	0.000307	CcSEcCtD
Ropinirole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000307	CcSEcCtD
Ropinirole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	6.71e-05	0.000307	CcSEcCtD
Ropinirole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	6.7e-05	0.000306	CcSEcCtD
Ropinirole—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000306	CcSEcCtD
Ropinirole—Vomiting—Montelukast—chronic obstructive pulmonary disease	6.69e-05	0.000305	CcSEcCtD
Ropinirole—Rash—Montelukast—chronic obstructive pulmonary disease	6.63e-05	0.000303	CcSEcCtD
Ropinirole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	6.62e-05	0.000303	CcSEcCtD
Ropinirole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	6.61e-05	0.000302	CcSEcCtD
Ropinirole—Depression—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000302	CcSEcCtD
Ropinirole—Headache—Montelukast—chronic obstructive pulmonary disease	6.59e-05	0.000301	CcSEcCtD
Ropinirole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000298	CcSEcCtD
Ropinirole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	6.51e-05	0.000297	CcSEcCtD
Ropinirole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000297	CcSEcCtD
Ropinirole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000297	CcSEcCtD
Ropinirole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.45e-05	0.000294	CcSEcCtD
Ropinirole—Malaise—Prednisolone—chronic obstructive pulmonary disease	6.43e-05	0.000294	CcSEcCtD
Ropinirole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000292	CcSEcCtD
Ropinirole—Rash—Salbutamol—chronic obstructive pulmonary disease	6.39e-05	0.000292	CcSEcCtD
Ropinirole—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.39e-05	0.000292	CcSEcCtD
Ropinirole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.39e-05	0.000292	CcSEcCtD
Ropinirole—Nausea—Formoterol—chronic obstructive pulmonary disease	6.38e-05	0.000291	CcSEcCtD
Ropinirole—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.38e-05	0.000291	CcSEcCtD
Ropinirole—Headache—Salbutamol—chronic obstructive pulmonary disease	6.35e-05	0.00029	CcSEcCtD
Ropinirole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.26e-05	0.000286	CcSEcCtD
Ropinirole—Nausea—Montelukast—chronic obstructive pulmonary disease	6.25e-05	0.000285	CcSEcCtD
Ropinirole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.17e-05	0.000282	CcSEcCtD
Ropinirole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.15e-05	0.000281	CcSEcCtD
Ropinirole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.000277	CcSEcCtD
Ropinirole—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.02e-05	0.000275	CcSEcCtD
Ropinirole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	5.99e-05	0.000274	CcSEcCtD
Ropinirole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000273	CcSEcCtD
Ropinirole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000272	CcSEcCtD
Ropinirole—Hallucination—Prednisone—chronic obstructive pulmonary disease	5.92e-05	0.00027	CcSEcCtD
Ropinirole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000267	CcSEcCtD
Ropinirole—Oedema—Prednisolone—chronic obstructive pulmonary disease	5.81e-05	0.000266	CcSEcCtD
Ropinirole—Shock—Prednisolone—chronic obstructive pulmonary disease	5.72e-05	0.000261	CcSEcCtD
Ropinirole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	5.68e-05	0.000259	CcSEcCtD
Ropinirole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.62e-05	0.000257	CcSEcCtD
Ropinirole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.000254	CcSEcCtD
Ropinirole—Flushing—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000252	CcSEcCtD
Ropinirole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000246	CcSEcCtD
Ropinirole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000245	CcSEcCtD
Ropinirole—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000243	CcSEcCtD
Ropinirole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.26e-05	0.00024	CcSEcCtD
Ropinirole—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.00024	CcSEcCtD
Ropinirole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.22e-05	0.000239	CcSEcCtD
Ropinirole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000238	CcSEcCtD
Ropinirole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000237	CcSEcCtD
Ropinirole—Pain—Prednisolone—chronic obstructive pulmonary disease	4.97e-05	0.000227	CcSEcCtD
Ropinirole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000223	CcSEcCtD
Ropinirole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000219	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	4.79e-05	0.000219	CcSEcCtD
Ropinirole—Anaemia—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000219	CcSEcCtD
Ropinirole—Agitation—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000217	CcSEcCtD
Ropinirole—Angioedema—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000216	CcSEcCtD
Ropinirole—Malaise—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000213	CcSEcCtD
Ropinirole—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000212	CcSEcCtD
Ropinirole—Syncope—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000212	CcSEcCtD
Ropinirole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.62e-05	0.000211	CcSEcCtD
Ropinirole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000208	CcSEcCtD
Ropinirole—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000205	CcSEcCtD
Ropinirole—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000204	CcSEcCtD
Ropinirole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000201	CcSEcCtD
Ropinirole—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000201	CcSEcCtD
Ropinirole—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000201	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.0002	CcSEcCtD
Ropinirole—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000199	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.28e-05	0.000196	CcSEcCtD
Ropinirole—Oedema—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000193	CcSEcCtD
Ropinirole—Infection—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000192	CcSEcCtD
Ropinirole—Shock—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.00019	CcSEcCtD
Ropinirole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.000189	CcSEcCtD
Ropinirole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.12e-05	0.000188	CcSEcCtD
Ropinirole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000187	CcSEcCtD
Ropinirole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000187	CcSEcCtD
Ropinirole—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000184	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000176	CcSEcCtD
Ropinirole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.85e-05	0.000176	CcSEcCtD
Ropinirole—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000175	CcSEcCtD
Ropinirole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000173	CcSEcCtD
Ropinirole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.72e-05	0.00017	CcSEcCtD
Ropinirole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000168	CcSEcCtD
Ropinirole—Rash—Prednisolone—chronic obstructive pulmonary disease	3.67e-05	0.000167	CcSEcCtD
Ropinirole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.66e-05	0.000167	CcSEcCtD
Ropinirole—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000166	CcSEcCtD
Ropinirole—Headache—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.000166	CcSEcCtD
Ropinirole—Constipation—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000165	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000159	CcSEcCtD
Ropinirole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000158	CcSEcCtD
Ropinirole—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.45e-05	0.000158	CcSEcCtD
Ropinirole—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.36e-05	0.000153	CcSEcCtD
Ropinirole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000153	CcSEcCtD
Ropinirole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000153	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.11e-05	0.000142	CcSEcCtD
Ropinirole—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000138	CcSEcCtD
Ropinirole—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.99e-05	0.000137	CcSEcCtD
Ropinirole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.89e-05	0.000132	CcSEcCtD
Ropinirole—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.000128	CcSEcCtD
Ropinirole—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.69e-05	0.000123	CcSEcCtD
Ropinirole—Rash—Prednisone—chronic obstructive pulmonary disease	2.66e-05	0.000122	CcSEcCtD
Ropinirole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.66e-05	0.000122	CcSEcCtD
Ropinirole—Headache—Prednisone—chronic obstructive pulmonary disease	2.65e-05	0.000121	CcSEcCtD
Ropinirole—Nausea—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000115	CcSEcCtD
Ropinirole—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.13e-05	0.000147	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.12e-05	0.000147	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000146	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.12e-05	0.000146	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.11e-05	0.000146	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.11e-05	0.000145	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.1e-05	0.000145	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.09e-05	0.000143	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.08e-05	0.000142	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.08e-05	0.000142	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	1.08e-05	0.000141	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000141	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000141	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.07e-05	0.00014	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.07e-05	0.00014	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.00014	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.00014	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.000139	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.000139	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000137	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000136	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000135	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.03e-05	0.000135	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.000133	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.01e-05	0.000133	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1e-05	0.000131	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1e-05	0.000131	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.95e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.94e-06	0.00013	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.89e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.74e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.69e-06	0.000127	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.68e-06	0.000127	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.65e-06	0.000126	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.63e-06	0.000126	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.58e-06	0.000125	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.55e-06	0.000125	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.43e-06	0.000124	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.42e-06	0.000123	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.38e-06	0.000123	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.37e-06	0.000123	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.37e-06	0.000123	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.35e-06	0.000122	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.35e-06	0.000122	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.32e-06	0.000122	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.27e-06	0.000121	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.27e-06	0.000121	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.2e-06	0.000121	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.2e-06	0.000121	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.13e-06	0.00012	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.11e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.11e-06	0.000119	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.01e-06	0.000118	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.97e-06	0.000118	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.92e-06	0.000117	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.78e-06	0.000115	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.78e-06	0.000115	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.7e-06	0.000114	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.66e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.62e-06	0.000113	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.57e-06	0.000112	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.55e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.52e-06	0.000112	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.5e-06	0.000111	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.48e-06	0.000111	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.43e-06	0.00011	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.42e-06	0.00011	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.41e-06	0.00011	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.38e-06	0.00011	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.38e-06	0.00011	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.38e-06	0.00011	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.37e-06	0.00011	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.36e-06	0.00011	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.28e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	8.19e-06	0.000107	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.18e-06	0.000107	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.18e-06	0.000107	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.17e-06	0.000107	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8e-06	0.000105	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.9e-06	0.000104	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.9e-06	0.000104	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	7.85e-06	0.000103	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.8e-06	0.000102	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.73e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.72e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.66e-06	0.0001	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.61e-06	9.97e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.6e-06	9.96e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.55e-06	9.9e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.55e-06	9.88e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.51e-06	9.84e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	7.51e-06	9.84e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.48e-06	9.8e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.44e-06	9.75e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.43e-06	9.74e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.38e-06	9.66e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.36e-06	9.65e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.34e-06	9.61e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.32e-06	9.59e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.18e-06	9.41e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.12e-06	9.33e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.1e-06	9.3e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.08e-06	9.28e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.07e-06	9.26e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.04e-06	9.22e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.02e-06	9.19e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.98e-06	9.14e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.92e-06	9.06e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.89e-06	9.03e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.83e-06	8.95e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.81e-06	8.92e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.8e-06	8.9e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.76e-06	8.86e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.75e-06	8.84e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.72e-06	8.81e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.72e-06	8.81e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.69e-06	8.77e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.62e-06	8.67e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.6e-06	8.65e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.58e-06	8.62e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.54e-06	8.57e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.49e-06	8.5e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.45e-06	8.46e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.45e-06	8.45e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.42e-06	8.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	6.38e-06	8.35e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.36e-06	8.34e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.28e-06	8.23e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.28e-06	8.23e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.27e-06	8.21e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.25e-06	8.19e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.18e-06	8.1e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.15e-06	8.06e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.14e-06	8.04e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.11e-06	8.01e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	6.1e-06	7.99e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.05e-06	7.93e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.04e-06	7.91e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.97e-06	7.83e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.97e-06	7.82e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.97e-06	7.82e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.96e-06	7.81e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.94e-06	7.79e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.87e-06	7.69e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.86e-06	7.68e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.76e-06	7.55e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.76e-06	7.54e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.75e-06	7.54e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.73e-06	7.5e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.7e-06	7.46e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.67e-06	7.43e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.66e-06	7.41e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.64e-06	7.39e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.63e-06	7.38e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.61e-06	7.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.6e-06	7.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.57e-06	7.3e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.54e-06	7.26e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.52e-06	7.23e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.5e-06	7.21e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.47e-06	7.17e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.46e-06	7.16e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.44e-06	7.13e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.44e-06	7.12e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.43e-06	7.12e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.39e-06	7.06e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.36e-06	7.03e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.34e-06	7e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.3e-06	6.94e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.29e-06	6.93e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.21e-06	6.82e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.19e-06	6.8e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.18e-06	6.78e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	6.78e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.1e-06	6.68e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.05e-06	6.62e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.04e-06	6.6e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.99e-06	6.54e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.97e-06	6.51e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.92e-06	6.45e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.89e-06	6.41e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.84e-06	6.34e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.83e-06	6.32e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.8e-06	6.3e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.74e-06	6.2e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.73e-06	6.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.67e-06	6.12e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.65e-06	6.09e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.64e-06	6.07e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.59e-06	6.01e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.57e-06	5.99e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.56e-06	5.98e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.52e-06	5.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.52e-06	5.93e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.52e-06	5.93e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.5e-06	5.89e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.44e-06	5.82e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.36e-06	5.71e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.36e-06	5.71e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.33e-06	5.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.3e-06	5.64e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-06	5.62e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.27e-06	5.59e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.24e-06	5.56e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.22e-06	5.52e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.21e-06	5.51e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.18e-06	5.48e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.18e-06	5.47e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.15e-06	5.44e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.15e-06	5.44e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.11e-06	5.38e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.1e-06	5.38e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.09e-06	5.36e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.07e-06	5.33e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.05e-06	5.31e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.04e-06	5.29e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4e-06	5.24e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.99e-06	5.22e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.97e-06	5.21e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.77e-06	4.93e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.76e-06	4.93e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.71e-06	4.86e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.71e-06	4.86e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.69e-06	4.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	4.81e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.66e-06	4.79e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.63e-06	4.76e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.53e-06	4.63e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.52e-06	4.61e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.51e-06	4.6e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.42e-06	4.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.37e-06	4.42e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.37e-06	4.41e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.35e-06	4.39e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.31e-06	4.33e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.23e-06	4.24e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.22e-06	4.21e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.13e-06	4.1e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.1e-06	4.06e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.05e-06	4e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.84e-06	3.72e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.79e-06	3.66e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.78e-06	3.64e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.72e-06	3.56e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.6e-06	3.4e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	3.33e-05	CbGpPWpGaD
